Consistent with the findings, the mRNA levels of PDIA1, PDIA3, PDIA4, and PDIA6 are typically overexpressed in HER2-enriched and Basal-like breast cancer subtypes as evidenced by gene expression data attained from the Gene Expression Atlas datasets [79]. The gene discussed is PDIA4; the disease is breast carcinoma.